Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary neopterin levels in hematologic malignancies.

G Santelli, A Marfella, G Abate

    Tumori
    |April 30, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021
    Same author

    Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice.

    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2021
    Same author

    Mitochondria and cellular redox state on the route from ageing to Alzheimer's disease.

    Mechanisms of ageing and development·2020
    Same author

    Monitoring Caco-2 to enterocyte-like cells differentiation by means of electric impedance analysis on printed sensors.

    Biochimica et biophysica acta. General subjects·2019
    Same author

    Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 Pathway.

    Oxidative medicine and cellular longevity·2018
    Same author

    Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2017
    Same journal

    End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

    Tumori·2026
    Same journal

    Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

    Tumori·2026
    Same journal

    Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

    Tumori·2026
    Same journal

    Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

    Tumori·2026
    Same journal

    Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

    Tumori·2026
    Same journal

    Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

    Tumori·2026
    See all related articles

    Urinary neopterin levels are significantly elevated in patients with hematologic malignancies. This biomarker may aid in diagnosing and monitoring non-Hodgkin

    Area of Science:

    • Oncology
    • Biochemistry
    • Immunology

    Background:

    • Hematologic malignancies, including non-Hodgkin's lymphomas, Hodgkin's disease, and multiple myeloma, represent a significant health concern.
    • Biomarkers for early diagnosis and monitoring of these cancers are crucial for improving patient outcomes.

    Purpose of the Study:

    • To investigate urinary neopterin excretion levels in patients with hematologic malignancies.
    • To compare neopterin levels between cancer patients and healthy controls.
    • To assess the correlation between neopterin levels and disease activity, stage, and symptoms.

    Main Methods:

    • Urinary neopterin levels were measured in 30 patients with non-Hodgkin's lymphomas, Hodgkin's disease, or multiple myeloma.
    • A control group of 30 healthy subjects was included for comparison.

    Related Experiment Videos

  • Statistical analysis was performed to compare neopterin levels and assess correlations.

    • Main Results:

    • Mean urinary neopterin excretion was significantly higher in cancer patients (576.01 +/- 620.37) compared to healthy controls (134.40 +/- 41.65) (p < 0.001).
    • Elevated neopterin levels (above the upper normal limit) were found in 82% (23/28) of patients with active disease.
    • A trend towards increased neopterin levels was observed with more advanced disease stages, including bone marrow involvement and constitutional symptoms.

    Conclusions:

    • Urinary neopterin is a potential biomarker for hematologic malignancies.
    • Neopterin evaluation may assist in the diagnosis and follow-up of patients with these cancers.
    • Further research is warranted to establish neopterin's role in clinical practice.